24201-207Level 3
Icatibant (icatibant)
**Product type:** Human Prescription Drug
**Active ingredient:** ICATIBANT ACETATE
**Strength:** 30 mg/3mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Hikma Pharmaceuticals USA Inc.
**Marketing category:** ANDA (ANDA211021)
**Pharmacologic class:** Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/24201-207Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.